Zobrazeno 1 - 10
of 475
pro vyhledávání: '"R. Stockler"'
Autor:
Grace Y. Kim, Ciara Conduit, Sophie O’Haire, Chia Yuen Chong, Olivia Baenziger, Jeremy Lewin, Benjamin Thomas, Nathan Lawrentschuk, Martin R. Stockler, Ian Olver, Peter Grimison, Ben Tran
Publikováno v:
Basic and Clinical Andrology, Vol 34, Iss 1, Pp 1-7 (2024)
Abstract Background Primary hypogonadism is a recognised complication in survivors of testicular cancer. However, secondary hypogonadism can result from other causes that suppress the hypothalamic-pituitary axis, including obesity, high dose glucocor
Externí odkaz:
https://doaj.org/article/4470c15dd2794376bcc33c5df672da1c
Autor:
K. M. Longo, S. R. Freitas, M. Pirre, V. Marécal, L. F. Rodrigues, J. Panetta, M. F. Alonso, N. E. Rosário, D. S. Moreira, M. S. Gácita, J. Arteta, R. Fonseca, R. Stockler, D. M. Katsurayama, A. Fazenda, M. Bela
Publikováno v:
Geoscientific Model Development, Vol 6, Iss 5, Pp 1389-1405 (2013)
Coupled Chemistry Aerosol-Tracer Transport model to the Brazilian developments on the Regional Atmospheric Modeling System (CCATT-BRAMS, version 4.5) is an on-line regional chemical transport model designed for local and regional studies of atmospher
Externí odkaz:
https://doaj.org/article/4c6dc7ee17c2454fb679c13836530bd5
Autor:
S. R. Freitas, K. M. Longo, M. F. Alonso, M. Pirre, V. Marecal, G. Grell, R. Stockler, R. F. Mello, M. Sánchez Gácita
Publikováno v:
Geoscientific Model Development, Vol 4, Iss 2, Pp 419-433 (2011)
The preprocessor PREP-CHEM-SRC presented in the paper is a comprehensive tool aiming at preparing emission fields of trace gases and aerosols for use in atmospheric-chemistry transport models. The considered emissions are from the most recent databas
Externí odkaz:
https://doaj.org/article/2fb9e5d14a48441c94bff316bbb8c171
Autor:
Angela Meade, Elena Frangou, Babak Choodari-Oskooei, James Larkin, Tom Powles, Grant D. Stewart, Laurence Albiges, Axel Bex, Toni K. Choueiri, Ian D. Davis, Tim Eisen, Alison Fielding, Craig Gedye, David J. Harrison, Rick Kaplan, Salena Mulhere, Paul Nathan, Grisma Patel, Jay Patel, Hannah Plant, Alastair Ritchie, Hannah Rush, Clare Shakeshaft, Martin R. Stockler, Cristina Suarez, Jemima Thompson, Nat Thorogood, Balaji Venugopal, Mahesh K.B. Parmar
Publikováno v:
Contemporary Clinical Trials Communications, Vol 42, Iss , Pp 101381- (2024)
Clinical trials to establish the efficacy of new agents in the adjuvant cancer setting typically take many years to complete. During that time, external factors can impact recruitment and reporting plans. An example is a new standard of care becoming
Externí odkaz:
https://doaj.org/article/152a532dd63f4c618fd32817ead311e1
Autor:
Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John, Steven Kao, Genni Newnham, Kenneth O’Byrne, Sagun Parakh, Victoria Bray, Kevin Jasas, Sonia Yip, Stephen Q. Wong, Sarah Ftouni, Jerick Guinto, Sushma Chandrashekar, Stephen Clarke, Nick Pavlakis, Martin R. Stockler, Sarah-Jane Dawson, Benjamin J. Solomon
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract In this phase II, single arm trial (ACTRN12617000720314), we investigate if alternating osimertinib and gefitinib would delay the development of resistance to osimertinib in advanced, non-small cell lung cancer (NSCLC) with the epidermal gro
Externí odkaz:
https://doaj.org/article/2aee772d175142968edb2117d86331be
Autor:
Ian Campbell, Neil Wetzig, Owen Ung, David Espinoza, Gelareh Farshid, John Collins, James Kollias, Val Gebski, Rebecca Mister, R. John Simes, Martin R. Stockler, Grantley Gill
Publikováno v:
Breast, Vol 70, Iss , Pp 70-75 (2023)
Background: Sentinel node-based management (SNBM) is the international standard of care for early breast cancer that is clinically node-negative based on randomised trials comparing it with axillary lymph node dissection (ALND) and reporting similar
Externí odkaz:
https://doaj.org/article/fa7ad81456e94eaaa1bd8cf78eb82bac
Autor:
Louise Emmett, Nikeith John, Sarennya Pathmanandavel, William Counter, Maria Ayers, Shikha Sharma, Shikha Agrawal, Aron Poole, Elizabeth Hovey, Ganes Pranavan, Craig Gedye, Girish Mallesara, Alex Guminski, Adrian Lee, Martin R. Stockler, Adam Hickey, Peter Eu, Anthony M. Joshua, Megan Crumbaker, Andrew Nguyen
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: 177 LuPSMA is an effective treatment in metastatic castrate-resistant prostate cancer with trials adopting a standardised dose interval. Adjusting treatment intervals utilising early response biomarkers may improve patient outcomes. Objec
Externí odkaz:
https://doaj.org/article/ac05d1fb3eb0484885744861a7656b88
Autor:
Ann Livingstone, Kathy Dempsey, Martin R. Stockler, Kirsten Howard, Georgina V. Long, Matteo S. Carlino, Alexander M. Menzies, Rachael L. Morton
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Adjuvant immunotherapy is revolutionising care for patients with resected stage III and IV melanoma. However, immunotherapy may be associated with toxicity, making treatment decisions complicated. This study aimed to identify fact
Externí odkaz:
https://doaj.org/article/64afe98444364a56b28713b3daaf6ca6
Autor:
Anupriya Agarwal, Ann Livingstone, Deme J. Karikios, Martin R. Stockler, Philip J. Beale, Rachael L. Morton
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Optimising the care of individuals with cancer without imposing significant financial burden related to their anticancer treatment is becoming increasingly difficult. The American Society of Clinical Oncology (ASCO) has recommende
Externí odkaz:
https://doaj.org/article/80abb7d222664d61bea0a974e17e4228
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/0d703ba5e6184d4ba0afb5379461ecf8